FIELD REFERENCE
Full criteria & treatment guidance
Use the matching product instructions
- This guide covers gel or paste. Use the separate SO-B-003 instructions for liquid glucose and tablets.
Check eligibility first
- Treat when the patient has altered mental status or an acute neurologic deficit, uses insulin or oral diabetes medication, and has glucose below 60 mg/dL—or 61–80 mg/dL when hypoglycemia is suspected.
- Ensure ALS is responding or present. The patient must be able to swallow and have an intact gag reflex.
- Do not give oral glucose to an unresponsive patient or one unable to swallow or without a gag reflex.
Give & reassess
- Confirm the product is intended for oral use.
- Place small portions of gel/paste between the cheek and gum on both sides, continuing until the tube is empty.
- Watch for choking, gagging, drooling, or uncontrolled coughing. Support the airway and suction when needed.
- Reassess mental status and vital signs at 5 minutes, then every 5 minutes until ALS arrives.
- Document the indication, administration time, route, amount, and response.
Other formulations in SO-B-003
- For an oral solution, give small amounts as tolerated until the intended product amount is taken.
- For chewable tablets, give two tablets, or one tablet for a child younger than 12. OCEMS does not specify a tablet strength, so verify the product instead of converting this to a gram dose.
Document the response
- Record why glucose was indicated, the preparation and amount, the route, the time, and the patient’s response. Repeat the initial assessment with mental status and vital signs every 5 minutes until ALS arrives.
- Maintain airway observation throughout. Improvement after sugar does not replace continued assessment or the required ALS response.
VISUAL FIELD REFERENCE
Oral glucose: eligibility → small portions → reassess
Adult and pediatric per OCEMS criteria · BLS
Check eligibility and swallowing
Treat when the patient has altered mental status or an acute neurologic deficit, uses insulin or oral diabetes medication, and has glucose below 60 mg/dL—or 61–80 mg/dL when hypoglycemia is suspected.
Ensure ALS is responding or present. The patient must be able to swallow and have an intact gag reflex.
Give gel / paste in small portions
Confirm the product is intended for oral use.
Place small portions of gel/paste between the cheek and gum on both sides, continuing until the tube is empty.
- Every 5 minutes
Watch the airway and reassess
Watch for choking, gagging, drooling, or uncontrolled coughing. Support the airway and suction when needed.
Reassess mental status and vital signs at 5 minutes, then every 5 minutes until ALS arrives.
- Do not give oral glucose to an unresponsive patient or one unable to swallow or without a gag reflex.
- This guide covers gel or paste. Use the separate SO-B-003 instructions for liquid glucose and tablets.
Selected checkpoints; read the complete guide for criteria, exclusions, doses, and ongoing care. SO-B-003
UNDERSTAND THE CARE
Why route safety is part of the glucose decision
The question is not only whether low glucose is suspected. Oral treatment also requires the patient to tolerate the product safely. Responsiveness, swallowing and airway reflexes must remain adequate throughout administration. The source’s eligibility criteria, including its glucose wording and diabetes-medication history, should be checked before choosing this BLS pathway.
Applying the guidance
Give the gel or paste in the small portions described in the guide and observe the patient as treatment proceeds. Gagging, coughing, drooling or declining consciousness should draw attention back to airway support. Liquid and tablet instructions are distinct; a tablet count cannot be translated to grams without knowing the product strength.
Putting it together
Teaching example: a patient initially accepts gel but becomes less responsive and stops swallowing normally. Stop treating oral delivery as safe, reassess the airway, support the patient and communicate the change to responding ALS.
Diagram text & teaching checkpoints
- Eligibility
- Check the local clinical criteria.
- Airway safety
- Responsive, swallowing, intact gag.
- Administration
- Small gel/paste portions with observation.
- Follow-up
- Repeat mental-status and vital-sign assessment.
Sources for this explanation
Original OCMedic teaching synthesis of the references below. Educational expansion updated ; this is not a new independent clinical-review date. Source-specific dates and limitations remain in the full guidance.